Elizabeth Warren @ewarren
For years, Merck brought in billions from one cancer drug. But its patent will expire soon, which means competitors could bring down costs. Now Merck’s trying to patent a slightly tweaked version just in time to protect their monopoly. I’m calling it out: https://t.co/I6nLpgGJrw — PolitiTweet.org